Technical Analysis for BPTH - Bio-Path Holdings Inc
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
Stochastic Buy Signal | Bullish | 0.00% | |
Spinning Top | Other | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Narrow Range Bar | Range Contraction | -3.00% | |
Wide Bands | Range Expansion | -3.00% | |
Oversold Stochastic | Weakness | -3.00% | |
NR7 | Range Contraction | -0.51% |
Alert | Time |
---|---|
Down 5% | about 8 hours ago |
Down 3% | about 8 hours ago |
Fell Below Previous Day's Low | about 8 hours ago |
Down 2 % | about 8 hours ago |
Down 1% | about 8 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/13/2024
Bio-Path Holdings, Inc., a biotechnology company, focuses on developing therapeutic products utilizing its proprietary liposomal delivery technology to systemically distribute nucleic acid drugs throughout the human body with a simple intravenous transfusion. Its lead product candidate, Liposomal Grb-2, is in a Phase I study for blood cancers and in preclinical studies for triple negative and inflammatory breast cancers. The company's other drug candidate, Liposomal Bcl-2, is ready for the clinic where it would be evaluated in lymphoma and solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Houston, Texas.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biotechnology Solid Tumors Acid Breast Cancer Lymphoma Cell Biology Treatment Of Breast Cancer Therapeutic Products Oncogenes Blood Cancers Apoptosis
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biotechnology Solid Tumors Acid Breast Cancer Lymphoma Cell Biology Treatment Of Breast Cancer Therapeutic Products Oncogenes Blood Cancers Apoptosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 35.83 |
52 Week Low | 1.85 |
Average Volume | 1,455,847 |
200-Day Moving Average | 6.95 |
50-Day Moving Average | 2.44 |
20-Day Moving Average | 2.34 |
10-Day Moving Average | 2.11 |
Average True Range | 0.31 |
RSI (14) | 40.12 |
ADX | 17.37 |
+DI | 27.58 |
-DI | 20.34 |
Chandelier Exit (Long, 3 ATRs) | 3.62 |
Chandelier Exit (Short, 3 ATRs) | 2.78 |
Upper Bollinger Bands | 3.16 |
Lower Bollinger Band | 1.52 |
Percent B (%b) | 0.25 |
BandWidth | 69.84 |
MACD Line | -0.16 |
MACD Signal Line | -0.15 |
MACD Histogram | -0.0141 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.36 | ||||
Resistance 3 (R3) | 2.38 | 2.25 | 2.29 | ||
Resistance 2 (R2) | 2.25 | 2.15 | 2.25 | 2.27 | |
Resistance 1 (R1) | 2.10 | 2.08 | 2.04 | 2.08 | 2.24 |
Pivot Point | 1.97 | 1.97 | 1.94 | 1.97 | 1.97 |
Support 1 (S1) | 1.82 | 1.87 | 1.76 | 1.80 | 1.64 |
Support 2 (S2) | 1.69 | 1.80 | 1.69 | 1.61 | |
Support 3 (S3) | 1.54 | 1.69 | 1.59 | ||
Support 4 (S4) | 1.52 |